ACTIVE

Dr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result43,1 k €-83,4 %over 1 year

Gross margin222,9 k €-58,0 %over 1 year

Equity1,8 M €-4,7 %over 1 year

Workforce1,0 ETP-16,7 %over 1 year

Identity

Source · BCE/KBO

Dr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE is a Private limited company incorporated in 2009. Its main activity is: General medical practice activities. Its registered office is in Gent. It employs on average 1,0 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0821.306.819
Incorporation: 10/12/2009
Legal form: Private limited company
Registered office: Meersstraat 142
9000 Gent · FlandreSee on map
Contributed capital: 18 600,00 €
Latest accounts: 31/12/2025
Average workforce: 1,0 ETP

Activities (NACE)

86210General medical practice activities· main 86210General medical practice activities 86220Specialist medical practice activities 86220Specialist medical practice activities

Joint committees (2)

330
330206

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 15 financial years

	2025		2023		2022		2021		2020
Income statement
Gross margin	222,9 k €	-58.0%	530,9 k €	+1.0%	525,8 k €	-27.3%	723,1 k €	+8.7%	665,5 k €
EBITDA	171,9 k €	-64.3%	481,2 k €	+5.6%	455,5 k €	-26.0%	615,4 k €	+22.6%	501,8 k €
Operating result	115,7 k €	-69.6%	380,7 k €	+7.0%	355,6 k €	-31.7%	520,9 k €	+26.0%	413,3 k €
Net result	43,1 k €	-83.4%	260,2 k €	-8.8%	285,4 k €	-27.0%	391,2 k €	+33.4%	293,2 k €
Balance sheet
Equity	1,8 M €	-4.7%	1,9 M €	+2.8%	1,8 M €	+3.9%	1,7 M €	+29.1%	1,3 M €
Total assets	2,4 M €	-1.8%	2,4 M €	+2.4%	2,4 M €	+13.5%	2,1 M €	+9.3%	1,9 M €
Cash	230,2 k €	-8.1%	250,5 k €	+4.5%	239,7 k €	-7.0%	257,7 k €	-19.2%	319 k €
Debts	621,4 k €	+7.2%	579,6 k €	+1.0%	573,6 k €	+60.2%	358,1 k €	-37.3%	570,8 k €
Other
Workforce	1,0 ETP	-16.7%	1,2 ETP	-25.0%	1,6 ETP	-33.3%	2,4 ETP	-22.6%	3,1 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 2,5 M€ and 5 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Xavier Janssens	Directorsince 03/12/2009Administrator - managerendedManagerended

Full financial information

Source · NBB

	2025	2023	2022	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	31/12/2025	31/12/2023	31/12/2022	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/07/2026	27/11/2024	27/11/2024	01/08/2022	02/08/2021	20/08/2020
General meeting	01/06/2026	30/10/2024	31/10/2023	01/06/2022	01/06/2021	27/07/2020
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	01/06/2026	31/07/2026	Dutch	PDF
Abridged model	31/12/2023	30/10/2024	27/11/2024	Dutch	PDF
Abridged model	31/12/2022	31/10/2023	27/11/2024	Dutch	PDF
Abridged model	31/12/2021	01/06/2022	01/08/2022	Dutch	PDF
Abridged model	31/12/2020	01/06/2021	02/08/2021	Dutch	PDF
Abridged model	31/12/2019	27/07/2020	20/08/2020	Dutch	PDF
Abridged model	31/12/2018	01/06/2019	29/07/2019	Dutch	PDF
Abridged model	31/12/2017	01/06/2018	25/07/2018	Dutch	PDF
Abridged model	31/12/2016	01/06/2017	24/07/2017	Dutch	PDF
Abridged model	31/12/2015	01/06/2016	31/07/2016	Dutch	PDF
Abridged model	31/12/2014	01/06/2015	20/07/2015	Dutch	PDF
Abridged model	31/12/2013	01/06/2014	31/07/2014	Dutch	PDF
Abridged model	31/12/2012	29/07/2013	31/07/2013	Dutch	PDF
Abridged model	31/12/2011	01/06/2012	31/08/2012	Dutch	PDF
Abridged model	31/12/2010	01/06/2011	21/12/2011	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 2,5 M€ and 5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

1 active

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Xavier Janssens	Directorsince 03/12/2009Administrator - managerendedManagerended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates02/10/2023
WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares17/04/2018
KAPITAAL - AANDELEN
PDF
Capital / shares11/04/2014
KAPITAAL - AANDELEN
PDF
Other21/12/2009
RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings15 filings

Mandates

Xavier Janssens

200920102011201220132014201520162017201820192020202120222023202420252026

Dr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISEJANSSENS REUMALEXDR. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE

Meersstraat 142, 9000 GentMeersstraat 12, 9000 Gent

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Meersstraat 142, 9000 GentCurrent	accounts 2025	Accounts 2025 · 2026-00378838
Meersstraat 12, 9000 Gent	accounts 2022 → 2023	Accounts 2023 · 2024-00605210
Meersstraat 142, 9000 Gent	accounts 2021	Accounts 2021 · 2022-20254881

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Dr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISECurrent	accounts 2025	Accounts 2025 · 2026-00378838
JANSSENS REUMALEX	accounts 2022 → 2023	Accounts 2023 · 2024-00605210
DR. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE	accounts 2010 → 2021	Accounts 2021 · 2022-20254881

Events

2025
Annual accounts 202543,1 k €↓
2025
Name changeDr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE
2023
Annual accounts 2023260,2 k €↓
2022
Annual accounts 2022285,4 k €↓
2022
Name changeJANSSENS REUMALEX
2021
Annual accounts 2021391,2 k €↑
2020
Annual accounts 2020293,2 k €↑
2019
Annual accounts 2019210,4 k €↓
2018
Annual accounts 2018248,8 k €↑
2017
Annual accounts 2017235,3 k €↓
2016
Annual accounts 2016235,7 k €↑
2015
Annual accounts 2015207,8 k €↓
2014
Annual accounts 2014236,2 k €↑
2013
Annual accounts 2013231,2 k €↑
2012
Annual accounts 2012167,7 k €↓
2011
Annual accounts 2011224,6 k €↓
2010
Annual accounts 2010383,7 k €
10/12/2009
IncorporationPrivate limited company

Dr. JANSSENS REUMALEX-REUMATOLOGIE, VERZEKERINGSGENEESKUNDE EN MEDISCHE EXPERTISE

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events